Share this article
Share this article
ResearchAndMarkets.com s offering.
Growing pharmaceutical industry, increasing uptake of multifunctional excipients, and the availability of high quality raw materials and excipients are the key driving factors of the market. Furthermore, increasing chronic disease prevalence around the world enhances the demand for pharmaceutical products and thereby excipients.
Market Segmentation
Recent Developments
2020: Evonik launched RESOMER Precise platform of custom functional excipients to precisely control the release profile of parenteral drug products.
In April 2019, Colorcon, Inc. (US) signed an agreement with DuPont Nutrition and Biosciences (US) in order to enhance the current product portfolio of CR Alliance products.